Discover
CMND
Clearmind Medicine Inc.
2.30
2 x 1.66
2 x 2.86
bid
ask
+
0.10
4.55%
2 @ 04:00 PM
2.30 -0.00 (0.17%)
| Ytd | -87.29% | |
| 1y | -99.34% |
2.19
day range
2.33
2.04
52 week range
524.00
| Open | 2.20 | Prev Close | 2.20 | Low | 2.19 | High | 2.33 | Mkt Cap | 3.42M |
| Vol | 176.44K | Avg Vol | 2.21M | EPS | -175.92 | P/E | N/A | Forward P/E | N/A |
| Beta | -1.51 | Short Ratio | 1.88 | Inst. Own | 16.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.29 | 200-d Avg | 95.33 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.57M | ||
| Research and Development Expense | 646.71K | ||
| Selling, General and Administrative Expense | 924.50K | ||
| Operating Income | -1.57M | ||
| Income Tax Expense | 3.31K | ||
| Net Income | -2.05M | ||
| Net Income Common Stock | -2.05M | ||
| Net Income Common Stock (USD) | -2.05M | ||
| Consolidated Income | -2.05M | ||
| Earnings per Basic Share | -6.78 | ||
| Earnings per Basic Share (USD) | -6.78 | ||
| Earnings per Diluted Share | -6.78 | ||
| Earning Before Interest & Taxes (EBIT) | -2.04M | ||
| Earning Before Interest & Taxes (USD) | -2.04M | ||
| Weighted Average Shares | 301.96K | ||
| Weighted Average Shares Diluted | 301.96K | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.42M | ||
| Cash and Equivalents (USD) | 11.42M | ||
| Investments | 2.20M | ||
| Investments Current | 2.18M | ||
| Investments Non-Current | 20.81K | ||
| Trade and Non-Trade Receivables | 146.38K | ||
| Current Assets | 14.32M | ||
| Property, Plant & Equipment Net | 87.97K | ||
| Total Assets | 14.52M | ||
| Debt Current | 41.24K | ||
| Total Debt | 85.59K | ||
| Current Liabilities | 2.99M | ||
| Debt Non-Current | 44.35K | ||
| Total Liabilities | 3.03M | ||
| Accumulated Retained Earnings (Deficit) | -33.78M | ||
| Accumulated Other Comprehensive Income | -21.25K | ||
| Shareholders Equity | 11.49M | ||
| Shareholders Equity (USD) | 11.49M | ||
| Assets Non-Current | 200.72K | ||
| Total Debt (USD) | 85.59K | ||
| Goodwill and Intangible Assets | 91.94K | ||
| Liabilities Non-Current | 44.35K | ||
| Trade and Non-Trade Payables | 811.43K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.90K | ||
| Net Cash Flow from Financing | 4.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.16M | ||
| Issuance (Purchase) of Equity Shares | 45.42K | ||
| Issuance (Repayment) of Debt Securities | 4.53M | ||
| Net Cash Flow from Investing | -650.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -650.00K | ||
| Net Cash Flow from Operations | -1.77M | ||
| Effect of Exchange Rate Changes on Cash | -1.95K | ||
| Share Based Compensation | 131.25K | ||